Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease. [PDF]
Zhang J, Xiao L, Yang W.
europepmc +1 more source
D-penicillamine induced status dystonicus is a unique but serious drug related complication in a subset of patients with Wilson disease. Patho-physiological basis of its occurrence is not known. It often responds poorly to anti dystonia medications.
Pradhan, Sunil +2 more
core
Biological Effects of D-Penicillamine on Copper Sulfate-Induced Possible Damage in the Caudate Nucleus: Role of Apoptotic Genes Bax, Bcl2, and Bax-Bcl2 Ratio. [PDF]
G Farag W, El-Kossi DMMH, Nafadi EKM.
europepmc +1 more source
D-Penicillamine-Induced Stevens-Johnson Syndrome in a Patient with Gold Cyanide Intoxication: A Case Report. [PDF]
Anuntrangsee T +2 more
europepmc +1 more source
Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. [PDF]
Zhao F +7 more
europepmc +1 more source
Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients. [PDF]
Lee EJ, Woo MH, Moon JS, Ko JS.
europepmc +1 more source
AN 18-YEAR FOLLOW-UP OF A CASE OF D-PENICILLAMINE-INDUCED ELASTOSIS PERFORANS SERPIGINOSA
Elastosis perforans serpiginosa (EPS) is a rare complication of chronic therapy with a high-dose of D-penicillamine (1 g daily for more than 5 years), characterized by the elimination of abnormal elastic fibers from the upper dermis through the epidermis.
CORTESI, GIORGIA +7 more
core
The Presence of D-Penicillamine during the In Vitro Capacitation of Stallion Spermatozoa Prolongs Hyperactive-Like Motility and Allows for Sperm Selection by Thermotaxis. [PDF]
Ruiz-Díaz S +7 more
europepmc +1 more source
Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis.
One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily.
Tygstrup, Niels +7 more
core

